In participants with high UTI risk at baseline
(n = 516), the incidence of clinically defined UTI was
lower with cranberry capsules than with placebo (62.8 vs
84.8 per 100 person-years at risk, P = .04); the treatment
effect was 0.74 (95% confidence interval (CI) = 0.57–
0.97)